Bulletin
Investor Alert

Poseida Therapeutics Inc.

NAS: PSTX

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Sep 24, 2020, 5:30 p.m.

/zigman2/quotes/205712311/composite

$

9.18

Change

0.00 0.00%

Volume

Volume 630

Quotes are delayed by 20 min

/zigman2/quotes/205712311/composite

Previous close

$ 9.50

$ 9.18

Change

-0.32 -3.37%

Day low

Day high

$9.10

$9.74

Open

52 week low

52 week high

$7.63

$17.62

Open

Annual Financials for Poseida Therapeutics Inc.

Fiscal year is January-December. All values USD millions. 2016201720182019 5-year trend
Sales/Revenue -9.77M2.99M--
Cost of Goods Sold (COGS) incl. D&A ---689,0001.19M
COGS excluding D&A -----
Depreciation & Amortization Expense -220,000676,000689,0001.19M
Depreciation -120,000376,000389,0001.19M
Amortization of Intangibles -100,000300,000300,000-
Gross Income ---(689,000)(1.19M)
2016201720182019 5-year trend
SG&A Expense -15M26M41.77M87.56M
Research & Development -9.86M21.2M32.78M70.29M
Other SG&A -5.13M4.8M8.99M17.26M
Other Operating Expense -----
Unusual Expense --(1.93M)2.53M6.68M
EBIT after Unusual Expense --(21.77M)(44.99M)(95.43M)
Non Operating Income/Expense -109,00037,000(821,000)2.56M
Non-Operating Interest Income -----
Equity in Affiliates (Pretax) -----
Interest Expense --558,0001.8M3.55M
Gross Interest Expense --558,0001.8M3.55M
Interest Capitalized -----
Pretax Income -(5.34M)(22.29M)(47.61M)(96.43M)
Income Tax -(765,000)(2.63M)(3.2M)(9.9M)
Income Tax - Current Domestic -2,0001,000--
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic -(167,000)(528,000)(202,000)-
Income Tax - Deferred Foreign -----
Income Tax Credits -600,0002.1M3M9.9M
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income -(4.58M)(19.66M)(44.4M)(86.53M)
Minority Interest Expense -----
Net Income -(4.58M)(19.66M)(44.4M)(86.53M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries -(4.58M)(19.66M)(44.4M)(86.53M)
Preferred Dividends -----
Net Income Available to Common -(4.58M)(19.66M)(44.4M)(86.53M)
EPS (Basic) -(0.08)(0.33)(0.75)(1.46)
Basic Shares Outstanding -59.32M59.32M59.32M59.32M
EPS (Diluted) -(0.08)(0.33)(0.75)(1.46)
Diluted Shares Outstanding -59.32M59.32M59.32M59.32M
EBITDA -(5.23M)(23.02M)(41.77M)(87.56M)
Link to MarketWatch's Slice.